b'NOW AVAILABLE ON THE57FEDERAL SUPPLY SCHEDULE.Reference contract #V797P-5229B to purchaseMyxredlinMYXREDLIN(Insulin Human) in 0.9% Sodium Chloride InjectionTHEFIRSTANDONLYREADY-T0-USEINSULINMAKE MYXREDLIN PART OF YOUR COMPOUNDING RISK REDUCTION STRATEGYHelp reduce insulin compounding errors with a commercially prepared option.ISMP and ASHP guidelines recommend use of a commercially prepared product instead of compounding as a risk reduction strategy for high-alert medications. 1,2Please visit www.baxterpi.com for Myxredlin (insulin human) in 0.9% Sodium Chloride Injection full PrescribingInformation.References1. American Society of Health-System Pharmacists. ASHP guidelines on preventing medication errors in hospitals. AM J Health-Syst Pharm.2018;75:1493-1517. 2. Institute for Safe Medication Practices (ISMP). ISMP Guidelines for Safe Preparation of Compounded Sterile Preparations; 2016. Baxter and Myxredlin are trademarks of Baxter International Inc. Baxter Healthcare Corporation Deerfield, IL 60015 USA USMP/MYX/20-00244/2020'